Guizhou Bailing Group Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the production and distribution of medicinal tablets, capsules, and syrups. With a Risk Rating Score of 36.5, the company is deemed as high risk according to its ESG score.